79 |
Surgery or chemoradiation for stage IB cervical cancer? How cost effectiveness impacts a complex decisionSurgery or chemoradiation for stage IB cervical cancer? How cost effectiveness impacts a complex decision
David E. CohnDavid E. Cohn
KMSID: 1079156 J Gynecol Oncol. 2014;25(2):79-80. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.79 |
|
81 |
Creating and field-testing the questionnaire for the assessment of knowledge about cervical cancer and its prevention among schoolgirls and female studentsCreating and field-testing the questionnaire for the assessment of knowledge about cervical cancer and its prevention among schoolgirls and female students
Katarzyna Jaglarz, Krzysztof A. Tomaszewski, Wojciech Kamzol, Mirosława Puskulluoglu, Krzysztof KrzemienieckiKatarzyna Jaglarz, Krzysztof A. Tomaszewski, Wojciech Kamzol, Mirosława Puskulluoglu, Krzysztof Krzemieniecki
KMSID: 1079157 J Gynecol Oncol. 2014;25(2):81-89. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.81 |
|
90 |
The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancerThe relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer
Shiho Kuji, Yasuyuki Hirashima, Satomi Komeda, Aki Tanaka, Masakazu Abe, Nobutaka Takahashi, Munetaka TakekumaShiho Kuji, Yasuyuki Hirashima, Satomi Komeda, Aki Tanaka, Masakazu Abe, Nobutaka Takahashi, Munetaka Takekuma
KMSID: 1079159 J Gynecol Oncol. 2014;25(2):90-96. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.90 |
|
97 |
Cost-utility analysis of treatments for stage IB cervical cancerCost-utility analysis of treatments for stage IB cervical cancer
Kanyarat Katanyoo, Naiyana Praditsitthikorn, Siriwan Tangjitgamol, Sumonmal Manusirivithaya, Busaba SupawattanabodeeKanyarat Katanyoo, Naiyana Praditsitthikorn, Siriwan Tangjitgamol, Sumonmal Manusirivithaya, Busaba Supawattanabodee
KMSID: 1079160 J Gynecol Oncol. 2014;25(2):97-104. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.97 |
|
105 |
Survival analysis of endometrial cancer patients with cervical stromal involvementSurvival analysis of endometrial cancer patients with cervical stromal involvement
Jonathan E. Frandsen, William T. Sause, Mark K. Dodson, Andrew P. Soisson, Thomas W. Belnap, David K. GaffneyJonathan E. Frandsen, William T. Sause, Mark K. Dodson, Andrew P. Soisson, Thomas W. Belnap, David K. Gaffney
KMSID: 1079098 J Gynecol Oncol. 2014;25(2):105-110. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.105 |
|
111 |
Comparison of laparoscopy and laparotomy for the management of early-stage ovarian cancer: surgical and oncological outcomesComparison of laparoscopy and laparotomy for the management of early-stage ovarian cancer: surgical and oncological outcomes
Yu-Jin Koo, Jung-Eun Kim, Young-Hwa Kim, Ho-Suap Hahn, In-Ho Lee, Tae-Jin Kim, Ki-Heon Lee, Jae-Uk Shim, Kyung-Taek LimYu-Jin Koo, Jung-Eun Kim, Young-Hwa Kim, Ho-Suap Hahn, In-Ho Lee, Tae-Jin Kim, Ki-Heon Lee, Jae-Uk Shim, Kyung-Taek Lim
KMSID: 1079099 J Gynecol Oncol. 2014;25(2):111-117. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.111 |
|
118 |
Clinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese womenClinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese women
Nobuhisa Yoshikawa, Hiroaki Kajiyama, Mika Mizuno, Kiyosumi Shibata, Michiyasu Kawai, Tetsuro Nagasaka, Fumitaka KikkawaNobuhisa Yoshikawa, Hiroaki Kajiyama, Mika Mizuno, Kiyosumi Shibata, Michiyasu Kawai, Tetsuro Nagasaka, Fumitaka Kikkawa
KMSID: 1079100 J Gynecol Oncol. 2014;25(2):118-123. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.118 |
|
124 |
Use of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in JapanUse of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in Japan
Kenichi Harano, Akihiro Hirakawa, Takayuki Kato, Keisuke Suzuki, Sachiko Watanabe, Noriyuki KatsumataKenichi Harano, Akihiro Hirakawa, Takayuki Kato, Keisuke Suzuki, Sachiko Watanabe, Noriyuki Katsumata
KMSID: 1079101 J Gynecol Oncol. 2014;25(2):124-129. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.124 |
|
130 |
Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancerMetronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer
Ho-Suap Hahn, Ki-Heon Lee, In-Ho Lee, Jae-Ho Lee, Chang-Sung Whang, Yeong-Woo Jo, Tae-Jin KimHo-Suap Hahn, Ki-Heon Lee, In-Ho Lee, Jae-Ho Lee, Chang-Sung Whang, Yeong-Woo Jo, Tae-Jin Kim
KMSID: 1079102 J Gynecol Oncol. 2014;25(2):130-135. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.130 |
|
136 |
Adjuvant therapy for endometrial cancerAdjuvant therapy for endometrial cancer
Maria C. DeLeon, Natraj R. Ammakkanavar, Daniela MateiMaria C. DeLeon, Natraj R. Ammakkanavar, Daniela Matei
KMSID: 1079103 J Gynecol Oncol. 2014;25(2):136-147. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.136 |
|
148 |
Building a successful fertility preservation program at a major cancer centerBuilding a successful fertility preservation program at a major cancer center
Jayeon Kim, Kenneth H Kim, Jennifer E MersereauJayeon Kim, Kenneth H Kim, Jennifer E Mersereau
KMSID: 1079105 J Gynecol Oncol. 2014;25(2):148-154. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.148 |
|
155 |
Consideration of EphA2 in relation to epithelial-mesenchymal transition in uterine endometrial cancerConsideration of EphA2 in relation to epithelial-mesenchymal transition in uterine endometrial cancer
Jee Young HwangJee Young Hwang
KMSID: 1079106 J Gynecol Oncol. 2014;25(2):155-155. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.155 |
|
157 |
Book Review: Primary, secondary, and tertiary prevention of cervical cancerBook Review: Primary, secondary, and tertiary prevention of cervical cancer
Hee Seung KimHee Seung Kim
KMSID: 1079107 J Gynecol Oncol. 2014;25(2):157-158. Published online 2014 April 9 DOI: http://dx.doi.org/10.3802/jgo.2014.25.2.157 |
|